Rusere Linah N, Lockbaum Gordon J, Henes Mina, Lee Sook-Kyung, Spielvogel Ean, Rao Desaboini Nageswara, Kosovrasti Klajdi, Nalivaika Ellen A, Swanstrom Ronald, Kurt Yilmaz Nese, Schiffer Celia A, Ali Akbar
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
Department of Biochemistry and Biophysics, and the UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
J Med Chem. 2020 Aug 13;63(15):8296-8313. doi: 10.1021/acs.jmedchem.0c00529. Epub 2020 Aug 3.
The design, synthesis, and X-ray structural analysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseudo-C-symmetric dipeptide isostere are described. A series of PIs were synthesized by incorporating bis-THF of darunavir on either side of the Phe-Phe isostere of lopinavir in combination with hydrophobic amino acids on the opposite P2/P2' position. Structure-activity relationship studies indicated that the bis-THF moiety can be attached at either the P2 or P2' position without significantly affecting potency. However, the group on the opposite P2/P2' position had a dramatic effect on potency depending on the size and shape of the side chain. Cocrystal structures of inhibitors with wild-type HIV-1 protease revealed that the bis-THF moiety retained similar interactions as observed in the darunavir-protease complex regardless of the position on the Phe-Phe isostere. Analyses of cocrystal structures and molecular dynamics simulations provide insights into optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isosteres.
本文描述了在拟C对称二肽等排体中含有双四氢呋喃(bis-THF)的混合型HIV-1蛋白酶抑制剂(PI)的设计、合成及X射线结构分析。通过将达芦那韦的双四氢呋喃引入洛匹那韦的苯丙氨酸-苯丙氨酸等排体两侧,并在相对的P2/P2'位置结合疏水氨基酸,合成了一系列PI。构效关系研究表明,双四氢呋喃部分可连接在P2或P2'位置,而不会显著影响活性。然而,相对的P2/P2'位置上的基团对活性有显著影响,这取决于侧链的大小和形状。抑制剂与野生型HIV-1蛋白酶的共晶体结构表明,无论在苯丙氨酸-苯丙氨酸等排体上的位置如何,双四氢呋喃部分都保留了与达芦那韦-蛋白酶复合物中观察到的类似相互作用。共晶体结构分析和分子动力学模拟为优化非磺酰胺二肽等排体中含有双四氢呋喃的HIV-1 PI提供了见解。